Inhaler

- Glaxo Group Limited
Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

FIG. 1 is a front perspective view of a first embodiment of the present design;

FIG. 2 is a front view of the first embodiment of the present design;

FIG. 3 is a rear view of the first embodiment of the present design;

FIG. 4 is a side view of the first embodiment of the present design;

FIG. 5 is an opposite side view of the first embodiment of the present design;

FIG. 6 is top view of the first embodiment of the present design;

FIG. 7 is bottom view of the first embodiment of the present design;

FIG. 8 is a front perspective view of a second embodiment of the present design;

FIG. 9 is a front view of the second embodiment of the present design;

FIG. 10 is a rear view of the second embodiment of the present design;

FIG. 11 is a side view of the second embodiment of the present design;

FIG. 12 is an opposite side view of the second embodiment of the present design;

FIG. 13 is top view of the second embodiment of the present design; and,

FIG. 14 is bottom view of the second embodiment of the present design.

Claims

The ornamental design for an inhaler, as shown and described.

Referenced Cited
U.S. Patent Documents
D348929 July 19, 1994 Paton
D370726 June 11, 1996 Padfield
D395147 June 16, 1998 Vidgren et al.
D433502 November 7, 2000 Rand
D492994 July 13, 2004 King et al.
D511208 November 1, 2005 Pardonge et al.
D515696 February 21, 2006 Lucking et al.
7325544 February 5, 2008 Bruna
D582543 December 9, 2008 Lucking
20050028815 February 10, 2005 Deaton et al.
Foreign Patent Documents
000688023-0001 May 2007 EM
000688023-0002 May 2007 EM
000688023-0003 May 2007 EM
000688023-0004 May 2007 EM
000688023-0005 May 2007 EM
000688023-0006 May 2007 EM
000688023-0007 May 2007 EM
000688023-0008 May 2007 EM
000688023-0009 May 2007 EM
000688023-0010 May 2007 EM
000688023-0011 May 2007 EM
000688023-0012 May 2007 EM
000688023-0013 May 2007 EM
000688023-0014 May 2007 EM
000688023-0015 May 2007 EM
000688023-0016 May 2007 EM
000688023-0017 May 2007 EM
000688023-0018 May 2007 EM
000688023-0019 May 2007 EM
000688023-0020 May 2007 EM
000688023-0021 May 2007 EM
000688023-0022 May 2007 EM
000688023-0023 May 2007 EM
000688023-0024 May 2007 EM
000688023-0025 May 2007 EM
000688023-0026 May 2007 EM
000688023-0027 May 2007 EM
000688023-0028 May 2007 EM
D1296192 March 2007 JP
D1296193 March 2007 JP
3001971220000 June 1997 KR
3003630260001 September 2004 KR
433889 February 1989 TW
495327 July 2002 TW
495328 July 2002 TW
500591 August 2002 TW
D111283 June 2006 TW
D122108 September 2006 TW
2006097745 September 2006 WO
2007028992 March 2007 WO
2008023019 February 2008 WO
Other references
  • U.S. Appl. No. 12/377,412, filed Feb. 13, 2009.
  • U.S. Appl. No. 29/322,977, filed Aug. 15, 2008.
Patent History
Patent number: D639931
Type: Grant
Filed: Mar 12, 2007
Date of Patent: Jun 14, 2011
Assignee: Glaxo Group Limited (Greenford, Middlesex)
Inventors: Gregor John McLennan Anderson (Ware), Matthew Spencer Collins (Shefford), David Vincent Elliman (Halstead), Richard David Lintern (Huntingdon), Andrew Michael Kelly (Ware), Allen John Pearson (Huntingdon), Paul Kenneth Rand (Ware), Mark Digby Teucher (Bristol), James Anthony West (Bristol)
Primary Examiner: Ian Simmons
Assistant Examiner: Christopher Lee
Attorney: James P. Riek
Application Number: 29/277,858
Classifications